Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats

G. Telegdy, A. Adamik

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The possible involvement of transmitters was measured by pretreating the animals with receptor blockers which alone did not influence the task, but in the doses used were effective with other neuropeptides. The receptor antagonist PACAP 6-38 (a PAC 1/VPAC2 receptor antagonist of PACAP-38 receptor), haloperidol (a non-selective dopamine receptor antagonist), phenoxybenzamine (an α1/α2β-adrenergic receptor antagonist), propranolol(a β-adrenergic receptor antagonist), bicuculline (a gamma-aminobutyric acid subunit A receptor antagonist), methysergide (a nonselective 5-HT2 serotonergic receptor antagonist), atropine (a nonselective muscarinic acetylcholine receptor antagonist), naloxone (a nonselective opioid receptor antagonist) and nitro-. l-arginine which acts by blocking the enzyme nitric oxide synthase, thereby blocking the nitric oxide synthesis, were tested. The following parameters were measured: the time spent in open arms/the time spent in total entries. PACAP-38 decreased the ratio of time spent in open arms to the time spent in total entries, indicating anxiogenic action. The total number of entries was not altered significantly either by PACAP-38 or by the receptor blockers. The following receptor blockers diminished the action of PACAP-38: PACAP 6-38,haloperidol, methysergide, naloxone and nitro-. l-arginine. Pretreatment with atropine, phenoxybenzamine, propranolol and bicuculline did not influence the action of PACAP-38 on the time spent in open arms.The results demonstrate that PACAP-38 administered into the lateral brain ventricle exerted anxiogenic action at 3. h following treatment. Pretreatment of the animals with various receptor blockers indicated that a nonselective dopaminergic receptor antagonist, 5HT2 serotonergic and opioid receptors, nitric oxide and PAC1 receptors are involved in the anxiogenic action induced by PACAP-38.

Original languageEnglish
Pages (from-to)333-338s
JournalBehavioural Brain Research
Volume281
DOIs
Publication statusPublished - Mar 5 2015

Fingerprint

Pituitary Adenylate Cyclase-Activating Polypeptide
Neurotransmitter Agents
Methysergide
Phenoxybenzamine
Adrenergic Antagonists
Bicuculline
Dopamine Antagonists
Haloperidol
Naloxone
Atropine
Propranolol
Arginine
Receptors, Vasoactive Intestinal Peptide, Type II
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
Narcotic Antagonists
Lateral Ventricles
Cholinergic Antagonists
Opioid Receptors
Muscarinic Receptors

Keywords

  • Anxiety
  • Male rats
  • Neurotransmitter mediation
  • PACAP-38

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Medicine(all)

Cite this

Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats. / Telegdy, G.; Adamik, A.

In: Behavioural Brain Research, Vol. 281, 05.03.2015, p. 333-338s.

Research output: Contribution to journalArticle

@article{7d4f5830a7924ef9b8c78739f32b25f7,
title = "Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats",
abstract = "The possible involvement of transmitters was measured by pretreating the animals with receptor blockers which alone did not influence the task, but in the doses used were effective with other neuropeptides. The receptor antagonist PACAP 6-38 (a PAC 1/VPAC2 receptor antagonist of PACAP-38 receptor), haloperidol (a non-selective dopamine receptor antagonist), phenoxybenzamine (an α1/α2β-adrenergic receptor antagonist), propranolol(a β-adrenergic receptor antagonist), bicuculline (a gamma-aminobutyric acid subunit A receptor antagonist), methysergide (a nonselective 5-HT2 serotonergic receptor antagonist), atropine (a nonselective muscarinic acetylcholine receptor antagonist), naloxone (a nonselective opioid receptor antagonist) and nitro-. l-arginine which acts by blocking the enzyme nitric oxide synthase, thereby blocking the nitric oxide synthesis, were tested. The following parameters were measured: the time spent in open arms/the time spent in total entries. PACAP-38 decreased the ratio of time spent in open arms to the time spent in total entries, indicating anxiogenic action. The total number of entries was not altered significantly either by PACAP-38 or by the receptor blockers. The following receptor blockers diminished the action of PACAP-38: PACAP 6-38,haloperidol, methysergide, naloxone and nitro-. l-arginine. Pretreatment with atropine, phenoxybenzamine, propranolol and bicuculline did not influence the action of PACAP-38 on the time spent in open arms.The results demonstrate that PACAP-38 administered into the lateral brain ventricle exerted anxiogenic action at 3. h following treatment. Pretreatment of the animals with various receptor blockers indicated that a nonselective dopaminergic receptor antagonist, 5HT2 serotonergic and opioid receptors, nitric oxide and PAC1 receptors are involved in the anxiogenic action induced by PACAP-38.",
keywords = "Anxiety, Male rats, Neurotransmitter mediation, PACAP-38",
author = "G. Telegdy and A. Adamik",
year = "2015",
month = "3",
day = "5",
doi = "10.1016/j.bbr.2014.12.039",
language = "English",
volume = "281",
pages = "333--338s",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats

AU - Telegdy, G.

AU - Adamik, A.

PY - 2015/3/5

Y1 - 2015/3/5

N2 - The possible involvement of transmitters was measured by pretreating the animals with receptor blockers which alone did not influence the task, but in the doses used were effective with other neuropeptides. The receptor antagonist PACAP 6-38 (a PAC 1/VPAC2 receptor antagonist of PACAP-38 receptor), haloperidol (a non-selective dopamine receptor antagonist), phenoxybenzamine (an α1/α2β-adrenergic receptor antagonist), propranolol(a β-adrenergic receptor antagonist), bicuculline (a gamma-aminobutyric acid subunit A receptor antagonist), methysergide (a nonselective 5-HT2 serotonergic receptor antagonist), atropine (a nonselective muscarinic acetylcholine receptor antagonist), naloxone (a nonselective opioid receptor antagonist) and nitro-. l-arginine which acts by blocking the enzyme nitric oxide synthase, thereby blocking the nitric oxide synthesis, were tested. The following parameters were measured: the time spent in open arms/the time spent in total entries. PACAP-38 decreased the ratio of time spent in open arms to the time spent in total entries, indicating anxiogenic action. The total number of entries was not altered significantly either by PACAP-38 or by the receptor blockers. The following receptor blockers diminished the action of PACAP-38: PACAP 6-38,haloperidol, methysergide, naloxone and nitro-. l-arginine. Pretreatment with atropine, phenoxybenzamine, propranolol and bicuculline did not influence the action of PACAP-38 on the time spent in open arms.The results demonstrate that PACAP-38 administered into the lateral brain ventricle exerted anxiogenic action at 3. h following treatment. Pretreatment of the animals with various receptor blockers indicated that a nonselective dopaminergic receptor antagonist, 5HT2 serotonergic and opioid receptors, nitric oxide and PAC1 receptors are involved in the anxiogenic action induced by PACAP-38.

AB - The possible involvement of transmitters was measured by pretreating the animals with receptor blockers which alone did not influence the task, but in the doses used were effective with other neuropeptides. The receptor antagonist PACAP 6-38 (a PAC 1/VPAC2 receptor antagonist of PACAP-38 receptor), haloperidol (a non-selective dopamine receptor antagonist), phenoxybenzamine (an α1/α2β-adrenergic receptor antagonist), propranolol(a β-adrenergic receptor antagonist), bicuculline (a gamma-aminobutyric acid subunit A receptor antagonist), methysergide (a nonselective 5-HT2 serotonergic receptor antagonist), atropine (a nonselective muscarinic acetylcholine receptor antagonist), naloxone (a nonselective opioid receptor antagonist) and nitro-. l-arginine which acts by blocking the enzyme nitric oxide synthase, thereby blocking the nitric oxide synthesis, were tested. The following parameters were measured: the time spent in open arms/the time spent in total entries. PACAP-38 decreased the ratio of time spent in open arms to the time spent in total entries, indicating anxiogenic action. The total number of entries was not altered significantly either by PACAP-38 or by the receptor blockers. The following receptor blockers diminished the action of PACAP-38: PACAP 6-38,haloperidol, methysergide, naloxone and nitro-. l-arginine. Pretreatment with atropine, phenoxybenzamine, propranolol and bicuculline did not influence the action of PACAP-38 on the time spent in open arms.The results demonstrate that PACAP-38 administered into the lateral brain ventricle exerted anxiogenic action at 3. h following treatment. Pretreatment of the animals with various receptor blockers indicated that a nonselective dopaminergic receptor antagonist, 5HT2 serotonergic and opioid receptors, nitric oxide and PAC1 receptors are involved in the anxiogenic action induced by PACAP-38.

KW - Anxiety

KW - Male rats

KW - Neurotransmitter mediation

KW - PACAP-38

UR - http://www.scopus.com/inward/record.url?scp=84920897057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920897057&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2014.12.039

DO - 10.1016/j.bbr.2014.12.039

M3 - Article

C2 - 25543171

AN - SCOPUS:84920897057

VL - 281

SP - 333-338s

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -